Aptar Pharma’s novel PureHale® ready-to-use nebulizer-like device was specifically developed to target the upper respiratory tract while minimizing deposition in the lower airways. PureHale provides a modern device option for the delivery of a fine mist for a variety of solutions to only the upper respiratory tract without significant deposition in the lungs and lower airways.
Delivery Device – Aerosol Deposition Characterization of Innovative PureHale® Technology Targeting the Upper Airways
The nose and upper respiratory system function as a path for air to enter the body while contributing to olfactory function, conditioning the breathed-in air and removing debris. Serving as a primary contact point with the environment, they can be a route for the entry of contaminants or disease as well as a site for healing and protection using the latest targeted delivery technologies.
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.